Aston Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$3.68M Sell
45,158
-4,661
-9% -$355K 2.24% 2
2016
Q1
$3.56M Buy
49,819
+1,347
+3% +$90.3K 2.09% 3
2015
Q4
$3.45M Sell
48,472
-929
-2% -$62.5K 2.03% 3
2015
Q3
$3.04M Sell
49,401
-6,560
-12% -$459K 1.73% 2
2015
Q2
$4.06M Sell
55,961
-10,838
-16% -$800K 1.92% 2
2015
Q1
$5.13M Sell
66,799
-4,687
-7% -$336K 2.23% 2
2014
Q4
$4.79M Sell
71,486
-91,446
-56% -$5.77M 2.04% 2
2014
Q3
$9.89M Buy
162,932
+10,387
+7% +$640K 2.33% 5
2014
Q2
$8.95M Buy
152,545
+51,599
+51% +$3.02M 2.05% 6
2014
Q1
$5.85M Buy
+100,946
New +$5.41M 1.37% 26

Other funds holding DGX

Aston Asset Management's DGX Position: Q2 2016 in Review

Aston Asset Management reduced its Quest Diagnostics (DGX) stake by 9.4% in Q2 2016, selling an estimated $355K and leaving 45,158 shares worth $3.68M. The position accounts for 2.24% of the portfolio, ranked #2.

Aston Asset Management first reported a position in DGX in Q1 2014 and has held it in 10 quarters since. The position peaked at $9.89M in Q3 2014. 558 funds tracked by Wall St. Rank hold DGX as of Q2 2016.

  • Aston Asset Management held 45,158 shares of Quest Diagnostics worth $3.68M as of Q2 2016.
  • Aston Asset Management sold 4,661 Quest Diagnostics shares in Q2 2016, an estimated $355K.
  • Quest Diagnostics made up 2.24% of Aston Asset Management's portfolio in Q2 2016, its #2 holding.
  • Aston Asset Management first reported a position in Quest Diagnostics in Q1 2014 and has held it in 10 quarters since.
  • Aston Asset Management's Quest Diagnostics position peaked at $9.89M in Q3 2014.
  • 558 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2016.

Based on Aston Asset Management's 13F filing for Q2 2016, filed 11 Aug 2016.